Validation of a bronchiolitis obliterans rat lung transplant model: the role of MMP-9 Source: Eur Respir J 2006; 28: Suppl. 50, 778s Year: 2006
Interferon-γ, IL-17 and MMP-9 in early and late bronchiolitis obliterans (BO) following experimental lung transplantation in rats Source: Eur Respir J 2007; 30: Suppl. 51, 517s Year: 2007
Pathophysiology of the lung allograft: pathways of graft rejection Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients Year: 2005
Bronchiolitis obliterans formation by epithelial-mesenchymal transition in lung transplant recipients Source: Annual Congress 2010 - Epithelial cells: cell biology and role in lung disease Year: 2010
Neutrophil mediated matrixmetalloproteinase activity is increased in bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2004; 24: Suppl. 48, 179s Year: 2004
Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2005; 25: 494-501 Year: 2005
Bronchial epithelial cell B7-1 and B7-2 mRNA expression after lung transplantation: a role in allograft rejection? Source: Eur Respir J 2002; 20: 165-169 Year: 2002
Elevated lung clearance index (LCI) as an early marker of future bronchiolitis obliterans (BOS) post lung transplant Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020
Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans Source: Eur Respir J 2004; 23: 384-390 Year: 2004
A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation Source: Eur Respir J 2011; 37: 164-172 Year: 2011
Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome Source: Eur Respir J 2008; 32: 670-677 Year: 2008
The Leuven experience of a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx) Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation Year: 2007
Infection and bronchiolitis obliterans syndrome in lung transplant recipients Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=44 Year: 2004
Post-transplant bronchiolitis obliterans Source: Eur Respir J 2003 Dec 01;22(6):1007-1018 Year: 2003
Static lung volumes in lung transplant recipients with bronchiolitis obliterans syndrome Source: Annual Congress 2011 - Lung function today and tomorrow II Year: 2011
Balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the development of bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2003; 22: Suppl. 45, 327s Year: 2003
Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1 Year: 2004
Hepatocyte growth factor (HGF) in lung allografts Source: Annual Congress 2005 - Recent advances in graft dysfunction after lung transplantation Year: 2005
Current status of lung transplantation Source: Eur Respir J 2003; 22: 57S-64S Year: 2003
IL8 and IL17 are upregulated in BAL fluid of lung transplant patients with bronchiolitis obliterans syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 465s Year: 2004